Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
Stefan WinterPascale FiselFlorian BüttnerAnne T NiesArnulf StenzlJens BedkeMatthias SchwabElke SchaeffelerPublished in: Science translational medicine (2018)